Biotech / Finance

PTC Therapeutics agrees to buy Marathon's DMD drug for $140m

From PBR - News
March 17, 2017 - 2:23am
PTC Therapeutics has agreed to acquire all rights to Emflaza (deflazacort) from Marathon Pharmaceuticals.


Continue reading this article »